More than half of post-surgery antibiotic prescriptions are inappropriate
04 December, 2017More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance.
Clarivate Analytics selected as ERA citation provider
24 August, 2017The Australian Research Council has announced its selection of Clarivate Analytics to provide citation information for the 2018 round of Excellence in Research for Australia (ERA), Australia's national research evaluation framework.
ISA releases Issues Paper for Australian innovation
27 March, 2017Innovation and Science Australia has released the 2030 Strategic Plan Issues Paper as part of its plan to drive the national conversation around the future of Australian innovation, science and research.
National Science Statement released
24 March, 2017Arthur Sinodinos has unveiled the National Science Statement, articulating the government's vision and objectives for Australian science.
6 key challenges for Australian innovation
16 March, 2017Innovation and Science Australia (ISA) Chair Bill Ferris has identified the six key innovation challenges Australia must address in order to become a top-tier innovation nation.
World biosurgery market expected to reach over $12.7bn by 2022
17 June, 2016The world biosurgery market is expected to reach almost $12.76 billion by 2022 with a CAGR of 8.1% from 2015 to 2022, according to a report by Allied Market Research.
Call for increased research-business collaboration
11 March, 2016Bill Ferris AC has told Australia's university leaders that increasing collaboration for commercialisation of research is both desirable and achievable.
Report calls for fairer pathology payments
22 February, 2016The Grattan Institute has released a report calling for the government to change the way it pays for pathology testing, in a move which would save up to $175 million a year.
Australia's research output is improving, says report
08 December, 2015'State of Australian University Research 2015–16' presents the outcomes of the Excellence in Research for Australia 2015 evaluations and details the quality of Australian university research benchmarked against world standards.
Introducing the Science Next Collaborative
07 August, 2015 by Sigma-AldrichIn order to empower the latest generation of scientists to better commercialise their research, Sigma-Aldrich has spearheaded a new initiative that forges a dynamic partnership between industry and academia.
Budget cuts are harder if people know the benefits of research
24 April, 2015 by Maggie Hardy, The University of QueenslandAn old academic joke you start to hear around federal budget time goes something like this: "Researchers could strike but no one would care, because no one would know we've gone until 10 or 15 years later."
Measuring the value of science: it's not always about the money
17 April, 2015 by Rod Lamberts, Australian National UniversityIt's perfectly sensible and understandable that science (and related sectors) would feel the need to account for themselves in financial or economic terms. But in doing this we need to be wary of getting lulled into believing that this is the only - or worse, the best - way of attributing value to science.
Mid-cap biotech companies increase revenues to $26.5 billion
09 April, 2015Research and consulting firm GlobalData has released a report comparing the competitive positions of 35 mid-cap biotechnology companies, finding an increase in combined total revenues from $24.8 billion in 2013 to $26.5 billion in 2014.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
